Track IKT and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
IKT - Inhibikase Therapeutics Inc (IKT) has a earnings per share of -$0.10, up 36.6% over the past year.
Latest EPS (Actual)
-$0.10
Beat Rate
12.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.09 | -$0.10 | Miss | -5.67% |
| Mar 2026 | -$0.12 | -$0.09 | Beat | +23.92% |
| Nov 2025 | -$0.13 | -$0.13 | Meet | -1.92% |
| Aug 2025 | -$0.08 | -$0.11 | Miss | -37.50% |
| May 2025 | -$0.09 | -$0.15 | Miss | -66.67% |
| Mar 2025 | -$0.09 | -$0.17 | Miss | -101.73% |
| Nov 2024 | -$0.48 | -$0.65 | Miss | -35.42% |
| Aug 2024 | -$0.67 | -$0.66 | Meet | +1.49% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.